Body weight and oral contraceptives are the most important modulators of serum CRP levels

References

• Hafner G., Endler T., Oppitz M., Merten U. P., Töpfer G., Dubois H., et al. Effects of standardization with the new international reference preparation for proteins in human serum on method comparability and reference values. Clin Lab 1995; 41: 743–8
   Google Scholar
• Ridker P. M., Buring J. E., Cook N. R., Rifai N. C‐reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 2003; 107: 391–7
   PubMed Web of Science ®Google Scholar
• Pearson T. A., Mensah G. A., Alexander R. W., Anderson J. L., Cannon R. O., Criqui M., et al. Markers of inflammation and cardiovascular disease. Circulation 2003; 107: 499–511
   PubMed Web of Science ®Google Scholar
• Danesh J., Muir J., Wong Y. K., Ward M., Gallimore J. R., Pepys M. B. Risk factors for coronary heart disease and acute‐phase proteins. A population‐based study. Eur Heart J 1999; 20: 954–9
   PubMed Web of Science ®Google Scholar
• Ford E. S. Does exercise reduce inflammation? Physical activity and C‐reactive protein among U.S. adults. Epidemiology 2002; 13: 561–8
   PubMed Web of Science ®Google Scholar
• Pannacciulli N., Cantatore F. P., Minenna A., Bellacicco M., Giorgino R., De Pergola G. C‐reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes Relat Metab Disord 2001; 25: 1416–20
   PubMed Web of Science ®Google Scholar
• Guven A., Cetinkaya A., Aral M., Sokmen G., Buyukbese M. A., Guven A., et al. High‐sensitivity C‐reactive protein in patients with metabolic syndrome. Angiology 2006; 57: 295–302
   PubMed Web of Science ®Google Scholar
• Leichtle A., Teupser D., Burkhardt R., Fiedler G. M., Thiery J. Cytokine independent reduction of us‐CRP in CHD‐patients supplemented with alpha‐tocopherol. Clin Chem Lab Med 2003; 41: A72
   Google Scholar
• Ikonomidis I., Lekakis J., Vamvakou G., Andreotti F., Nihoyannopoulos P. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: Affects of aspirin treatment. Am Heart J 2005; 149: 832–9
   PubMed Web of Science ®Google Scholar
• Ridker P. M., Hennekens C. H., Rifai N., Buring J. E., Manson J. E. Hormone replacement therapy and increased plasma concentration of C‐reactive protein. Circulation 1999; 100: 713–6
   PubMed Web of Science ®Google Scholar
• Van Rooijen M., Hansson L. O., Frostegard J., Silveira A., Hamsten A., Bremme K. Treatment with combined oral contraceptives induces a rise in serum C‐reactive protein in the absence of a general inflammatory response. J Thromb Haemost 2006; 4: 77–82
   PubMed Web of Science ®Google Scholar
• Yudkin J. S., Stehouver C. D. A., Emeis J. J., Coppack S. W. C‐reactive protein in healthy subjects; associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 9: 972–8
   Web of Science ®Google Scholar
• Kluft C., Gevers Leuven J. A., Helmerhorst F. M., Krans H. M. J. Pro‐inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment. Vasc Pharmacol 2002; 39: 149–54
   PubMed Web of Science ®Google Scholar
• Fröhlich M., Döring A., Imhof A., Hutchinson W. L., Pepys M. B., Koenig W. Oral contraceptive use is associated with a systemic acute phase response. Fibrinolysis Proteolysis 1999; 13: 239–44
   Google Scholar
• Dreon D. M., Slavin J. L., Phinney S. D. Oral contraceptive use and increased plasma concentration of C‐reactive protein. Life Sciences 2003; 73: 1245–52
   PubMed Web of Science ®Google Scholar
• Torzewski J., Torzewski M., Bowyer D. E., Fröhlich M., Koenig W., Waltenberger J., et al. C‐reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998; 18: 1386–92
   PubMed Web of Science ®Google Scholar
• Torzewski M., Rist C., Mortensen R. F., Zwaka T. P., Bieneck M., Waltenberger J., et al. C‐reactive protein in the arterial intima. Arterioscler Thromb Vasc Biol 2000; 20: 2094–9
   PubMed Web of Science ®Google Scholar
• Fu T., Boensztajn J. Macrophage uptake of low‐density lipoprotein bound to aggregated C‐reactive protein: Possible mechanism of foam‐cell formation in atherosclerotic lesions. Biochem J 2002; 366: 195–201
   PubMed Web of Science ®Google Scholar